AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hand & Wrist Pyrocarbon Implants Outcomes Clinical Study

Recruitingn/aAges 18 Years - anyAllStryker Trauma and Extremities
💬

In plain words

What the trial is, and whether it could suit you

HaWPYC is an international Post-Market Clinical Follow-up (PMCF) to collect post-market safety and performance data on commercially available Pyrocarbon (PyC) hand and wrist implants used in this study. Data may be used for Post-Market Surveillance, and regulatory requirements.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * 18 years or older at the time he/she receives the information and signs the informed consent (when applicable as per local regulatory requirements), * Informed on the study and willing to sign an informed consent form approved by Institutional Review Board or Ethics Committee, * Willing and able to comply with the requirements of the study protocol, * For prospective inclusion: considered for treatment with one of PyC Hand/Wrist study implants (primary or revision surgery), * For "ambispective" inclusion: must have undergone a Hand or Wrist arthroplasty with a PyC Hand/Wrist study implant before the date of first site initiation visit, * Follow-up visits (at least the last two) must be prospective, * Patient must have complete information available for each completed visit Exclusion Criteria: * Patient pertaining to one of the categories referred to as "vulnerable population" in the French Law (articles L. 1121-5 to L. 1121-8 of the French Public Health Code), or as "particularly vulnerable persons" in the Swiss Federal Law (Chapter 3, Sections 1 to 4 of CC 810.30 Federal Act on Research involving Human Beings - Human Research Act, HRA), * Patient unable to comply with the study procedures based on the judgment of the investigator (e.g. cannot comprehend study questions, inability to keep scheduled assessment times), * Any medical condition that could impact on the study outcomes functional signification at the investigator's discretion (e.g., neuropathy, allergy…)
💊

What it tests

  • Not listed
📍

Where

4 sites
Clinique du Parc
Lyon, France
Espace Médical Vauban
Paris, France
Institut de la Main Nantes-Atlantique - Pôle Santé-Atlantique
Saint-Herblain, France
Orthopedic Surgeon (Dr. med. Dietmar Bignion)
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy